FOXO TECHNOLOGIES INC. Proceeds from Issuance of Preferred Stock and Preference Stock
FOXO TECHNOLOGIES INC. (FOXO) reported Proceeds from Issuance of Preferred Stock and Preference Stock of $28.00 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock · last filed 2023-08-10
- FOXO TECHNOLOGIES INC. proceeds from issuance of preferred stock and preference stock for the quarter ending 2022-06-30 was $5.50M.
- FOXO TECHNOLOGIES INC. proceeds from issuance of preferred stock and preference stock for the quarter ending 2022-03-31 was $22.50M.
- FOXO TECHNOLOGIES INC. proceeds from issuance of preferred stock and preference stock for the quarter ending 2021-12-31 was $0.00.
- FOXO TECHNOLOGIES INC. proceeds from issuance of preferred stock and preference stock for fiscal 2021 was $3.75M.
| Period end | Proceeds from Issuance of Preferred Stock and Preference Stock 3 month | Proceeds from Issuance of Preferred Stock and Preference Stock 6 month | Proceeds from Issuance of Preferred Stock and Preference Stock 9 month | Proceeds from Issuance of Preferred Stock and Preference Stock 12 month |
|---|---|---|---|---|
| 2022-06-30 | $5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $28.00M 10-Q · filed 2023-08-10 | $28.00M derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | $22.50M 10-Q · filed 2023-05-11 | $22.50M derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.75M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $3.75M 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |